SOURCE: IBC Life Sciences

December 11, 2008 12:15 ET

IBC Life Sciences Announces Biopharmaceutical Development & Production Week March 2-6, 2009 in Carlsbad, California

WESTBOROUGH, MA--(Marketwire - December 11, 2008) - IBC is pleased to announce Biopharmaceutical Development & Production Week which includes five conferences focused on these specific biopharmaceutical disciplines: antibody development and production, outsourcing manufacturing, process validation, technology transfer and non-antibody protein therapeutics.

This week long event provides biopharmaceutical professionals the opportunity to network face-to-face with 700 industry peers and is comprised of over 120 presentations that include exclusive case studies, interactive workshop sessions, industry panels, and strategic discussion groups.

Kicking off the week is IBC's Outsourcing Manufacturing of Biopharmaceuticals, Process Validation for Biopharmaceuticals, and Technology Transfer for Biopharmaceuticals conferences being held on March 2-3, 2009. Then on March 4-5, 2009 IBC will host its Inaugural Non-Antibody Protein Therapeutics Development & Production conference.

Rounding out the week is IBC's 22nd International Antibody Development & Production conference. This conference provides the latest scientific and technical approaches to developing and producing robust processes across the spectrum, including the most critical stages of upstream and downstream processing. In addition, IBC has expanded this program to include strategy discussion forums, interactive workshops and panel discussions that will provide valuable and uncensored insight on today's most critical topics.

Antibody Development & Production features three keynote presentations:

--  How do We Get to g/L Using Fed-Batch Technology? What are the
    Limitations?
    Thomas Ryll, Ph.D., Director of Cell Culture Development, Biogen Idec
--  Thoughts from the New Kids on the Biotherapeutics Block
    Rick Rutter, Ph.D., Vice President, Pharmaceutical Sciences, Biologics,
    Pfizer, Inc.
--  Next Generation Commercial Processes
    Timothy S. Charlebois, Ph.D., Director, Cell & Molecular Sciences, Wyeth
    BioPharma
    

Attendees may choose to attend one conference or attend for the week with the dual conference pass. This event also includes an exhibit hall, open to attendees. Complete details on these events can be found at www.IBCLifeSciences.com/bdpweek.

Writers and editors are encouraged to attend. For a press pass please contact Dawn O'Connor at doconnor@ibcusa.com.

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. For more information, visit www.IBCLifeSciences.com.

Contact Information

  • Contact:
    Dawn O'Connor
    IBC Life Sciences
    (508) 614-1679
    Email Contact